About
Dr. Johnson has extensive strategy, corporate and business development experience, and has generated more than $2 billion in transaction value. Most recently she served as Senior Vice President, Business Development at aTyr Pharma. Previously, Dr. Johnson was Vice President, Business and Corporate Development at Momenta Pharmaceuticals, Inc. (MNTA), where she managed corporate strategy and negotiated transactions related to the company's proprietary technology platform and product portfolio. Dr. Johnson served as a Principal at Atlas Venture, where she was responsible for new biotech investments and the management of portfolio companies. She also served as head of business development at Regeneron Pharmaceuticals,. Dr. Johnson received her Doctorate from the Johns Hopkins School of Medicine's Department of Biological Chemistry.
Position in the VCSift Database
- • 3 investors hold the Senior Vice President, Business Development role in VCSift. Catharine Johnson is one of them.
- • 491 investors are based in Cambridge, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Cambridge, US
Contact Information
Find more investors like Catharine
Search Investors